Concepedia

Eva Altmann

EA

Statistics

Publications

31

Citations

1.5K

H-Index

22

Active since

1988

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

University of Lausanne

University of Basel

Eva Altmann is an author at Novartis (Switzerland) specializing in medicinal chemistry, drug discovery, and enzyme inhibition.

ORCID

Publications per year

1988–2025

31

Publications

31

The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time

Peter Ertl, Eva Altmann, Jeffrey M. McKenna · Journal of Medicinal Chemistry · 2020 · 406 citations

, , +9

Targeted inhibition of the COP9 signalosome for treatment of cancer

Anita Schlierf, Eva Altmann, Jean Quancard et al. · Nature Communications · 2016 · 204 citations · Full text

, , +17

The Construction of New Proteins. Part III. Artificial folding units by assembly of amphiphilic secondary structures on a template

Manfred Mutter, Eva Altmann, Karl‐Heinz Altmann et al. · Helvetica Chimica Acta · 1988 · 92 citations

, , +14

Novel Purine Nitrile Derived Inhibitors of the Cysteine Protease Cathepsin K

Eva Altmann, Sandra W. Cowan‐Jacob, Martin Missbach · Journal of Medicinal Chemistry · 2004 · 72 citations · Full text

, , +12

7-Alkyl- and 7-Cycloalkyl-5-aryl-pyrrolo[2,3-d]pyrimidines—potent inhibitors of the tyrosine kinase c-Src

Leo Widler, Jonathan A. Green, Martin Missbach et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 52 citations · Full text

, , +11

1–5 of 31